CP

Canaan Partners X LLC

Concentrated strategyLong-term holderQuality / disciplined sizing

Total reported value

$74.7M

Reporting period: 2023-09-30 · Number of holdings: 2

Canaan Partners X LLC disclosed 2 holdings in its latest 13F filing for the period ending 2023-09-30, with total reported value of $74.7M and a quarterly turnover rate of 0.0%.

Personality snowflake

Concentration
100
Portfolio Stability
0
Momentum/Contrarian
50
Sector conviction
0
Diversification
4
Sizing Uniformity
86.97

Recent moves

No holding changes this quarter

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1IDYAIdeaya Biosciences INCStock-Other96.06%
2Stock-Other3.94%

Holding changes this quarter

Position changes disclosed by Canaan Partners X LLC for the quarter ending 2023-09-30, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction

FAQ

What is Canaan Partners X LLC and what type of investor is it?
Canaan Partners X LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2023-09-30), the firm manages a tracked equity portfolio valued at approximately $74.7M, spread across 2 disclosed positions.
What are Canaan Partners X LLC's largest equity positions?
Based on the latest 13F filing, Canaan Partners X LLC's top holdings by market value are: 1. Ideaya Biosciences INC (IDYA) — $71.8M (96.1%) 2. — $2.9M (3.9%)
What changes did Canaan Partners X LLC make in its most recent portfolio filing?
No notable portfolio changes were recorded for Canaan Partners X LLC in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Canaan Partners X LLC focus on?
Sector breakdown data is not yet available for Canaan Partners X LLC. Check back after the next 13F processing cycle.